State SC
Clinical Trials in South Carolina
Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Carolina
Frequently Asked Questions — Clinical Trials in South Carolina
How many clinical trials are currently recruiting in South Carolina?
ClinicalMetric currently tracks 188 actively recruiting clinical trials with at least one location in South Carolina. The total number of registered studies—including active but not currently enrolling trials—is 188. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Carolina?
South Carolina hosts clinical trials across a broad range of medical conditions, including Asthma, Opioid Use Disorder, Head and Neck Squamous Cell Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Carolina?
To join a clinical trial in South Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in South Carolina
NCT07517237 N/A
Recruiting
taVNS + CCT for Neurocognitive Rehab
Condition
Psychosocial Well-being
Enrollment
20 pts
Location
United States
Sponsor
Medical University of South Ca
NCT03460977 Phase 1
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration R...
Condition
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Enrollment
453 pts
Location
United States, Bulgaria, China
Sponsor
Pfizer
NCT05890729 Phase 1, Phase 2
Recruiting
A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Condition
Pulmonary Sarcoidosis
Enrollment
94 pts
Location
United States, Czechia, Denmark
Sponsor
Xentria, Inc.
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
NCT06076967 N/A
Recruiting
Mindfulness Intervention for College Students With ADHD
Condition
Attention Deficit Hyperactivity Disorder
Enrollment
100 pts
Location
United States
Sponsor
University of Alabama, Tuscalo
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
NCT06588855 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Ulcerative Colitis
Enrollment
350 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07398417 Phase 3
Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal ...
Condition
Fibromyalgia
Enrollment
620 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
NCT06372106 N/A
Recruiting
Project Mountain - Comparing SpO2 and SaO2 for Accuracy
Condition
SpO2
Enrollment
560 pts
Location
United States
Sponsor
Philips Clinical & Medical Aff
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT03941379 N/A
Recruiting
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Condition
Choroidal Melanoma
Enrollment
500 pts
Location
United States
Sponsor
Aura Biosciences
NCT07211997 N/A
Recruiting
FebriDx® Pediatric Validation Study
Condition
Acute Respiratory Infections (ARIs)
Enrollment
800 pts
Location
United States
Sponsor
Lumos Diagnostics
NCT06504446 Phase 2
Recruiting
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With...
Condition
Refractory or Unexplained Chronic Cough
Enrollment
455 pts
Location
United States, Belgium, Canada
Sponsor
Nocion Therapeutics
NCT05156398 Phase 3
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migrai...
Condition
Migraine
Enrollment
640 pts
Location
United States, Canada, France
Sponsor
Pfizer
NCT06635148 Phase 2
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Part...
Condition
Geographic Atrophy
Enrollment
274 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06291376 Phase 3
Recruiting
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
Condition
Immunoglobulin A Nephropathy
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Alexion Pharmaceuticals, Inc.
NCT06689085 Phase 3
Recruiting
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTE...
Condition
Hypogonadism, Male
Enrollment
100 pts
Location
United States
Sponsor
Halozyme Therapeutics
NCT06064877 Phase 3
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recur...
Condition
Metastatic Head-and-neck Squamous-cell Carcinoma
Enrollment
410 pts
Location
United States, Australia, Belgium
Sponsor
AVEO Pharmaceuticals, Inc.
NCT07001800 Phase 2, Phase 3
Recruiting
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis...
Condition
Moderate Aortic Valve Stenosis
Enrollment
1,276 pts
Location
United States, Canada
Sponsor
Kardigan, Inc.
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States
Sponsor
NRG Oncology
NCT05248230 Phase 2
Recruiting
4D-710 in Adult Patients With Cystic Fibrosis
Condition
Cystic Fibrosis Lung
Enrollment
30 pts
Location
United States
Sponsor
4D Molecular Therapeutics
NCT06253130 Phase 1, Phase 2
Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants Wi...
Condition
Advanced Solid Tumor
Enrollment
156 pts
Location
United States, Australia, Canada
Sponsor
Eikon Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology